AL2SI Fundamental Analysis - 2CRSI SA

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to AL2SI. AL2SI was compared to 28 industry peers in the Technology Hardware, Storage & Peripherals industry. While AL2SI seems to be doing ok healthwise, there are quite some concerns on its profitability. AL2SI has a valuation in line with the averages, but on the other hand it scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year AL2SI has reported negative net income.

In the past 5 years AL2SI always reported negative net income.

In multiple years AL2SI reported negative operating cash flow during the last 5 years.

1.2 Ratios

The Return On Assets of AL2SI (-8.34%) is worse than 78.57% of its industry peers.

Looking at the Return On Equity, with a value of -23.59%, AL2SI is doing worse than 67.86% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-8.34%
ROE	-23.59%
ROIC	N/A

ROA(3y)-6%

ROA(5y)-4.94%

ROE(3y)-24.19%

ROE(5y)-19.4%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 95.25%, AL2SI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.

In the last couple of years the Gross Margin of AL2SI has remained more or less at the same level.

The Profit Margin and Operating Margin are not available for AL2SI so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	95.25%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.01%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

AL2SI does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, AL2SI has more shares outstanding

AL2SI has a better debt/assets ratio than last year.

2.2 Solvency

AL2SI has an Altman-Z score of 4.32. This indicates that AL2SI is financially healthy and has little risk of bankruptcy at the moment.

Looking at the Altman-Z score, with a value of 4.32, AL2SI is in the better half of the industry, outperforming 75.00% of the companies in the same industry.

AL2SI has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.

AL2SI has a Debt to Equity ratio of 0.39. This is in the better half of the industry: AL2SI outperforms 67.86% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.39
Debt/FCF	N/A
Altman-Z	4.32

ROIC/WACCN/A

WACC7.24%

2.3 Liquidity

A Current Ratio of 1.69 indicates that AL2SI should not have too much problems paying its short term obligations.

AL2SI's Current ratio of 1.69 is fine compared to the rest of the industry. AL2SI outperforms 60.71% of its industry peers.

AL2SI has a Quick Ratio of 1.08. This is a normal value and indicates that AL2SI is financially healthy and should not expect problems in meeting its short term obligations.

AL2SI has a Quick ratio (1.08) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Current Ratio	1.69
Quick Ratio	1.08

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

AL2SI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 64.98%, which is quite impressive.

The Revenue has decreased by -2.51% in the past year.

The Revenue has been growing slightly by 3.08% on average over the past years.

EPS 1Y (TTM)64.98%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%192.84%

Revenue 1Y (TTM)-2.51%

Revenue growth 3Y3.08%

Revenue growth 5YN/A

Sales Q2Q%85.45%

3.2 Future

AL2SI is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -46.37% yearly.

AL2SI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.16% yearly.

EPS Next Y2733.33%

EPS Next 2Y558.28%

EPS Next 3Y271.65%

EPS Next 5Y-46.37%

Revenue Next Year17.2%

Revenue Next 2Y34.67%

Revenue Next 3Y25.87%

Revenue Next 5Y14.16%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

AL2SI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Based on the Price/Forward Earnings ratio of 5.81, the valuation of AL2SI can be described as very cheap.

Compared to the rest of the industry, the Price/Forward Earnings ratio of AL2SI indicates a rather cheap valuation: AL2SI is cheaper than 96.43% of the companies listed in the same industry.

AL2SI's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.66.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	5.81

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AL2SI is valued a bit more expensive than the industry average as 64.29% of the companies are valued more cheaply.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	72.43

4.3 Compensation for Growth

AL2SI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

AL2SI's earnings are expected to grow with 271.65% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y558.28%

EPS Next 3Y271.65%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for AL2SI!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

2CRSI SA

EPA:AL2SI (9/8/2025, 7:00:00 PM)

7.78

+0.01 (+0.13%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupTechnology Hardware & Equipment

GICS IndustryTechnology Hardware, Storage & Peripherals

Earnings (Last)04-01 2025-04-01/amc

Earnings (Next)N/A N/A

Inst Owners8.37%

Inst Owner ChangeN/A

Ins Owners50.96%

Ins Owner ChangeN/A

Market Cap173.73M

Analysts86

Price Target12.09 (55.4%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)36.21%

PT rev (3m)36.21%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)49.12%

EPS NY rev (3m)49.12%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)6.81%

Revenue NY rev (3m)6.81%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	5.81
P/S	0.97
P/FCF	N/A
P/OCF	N/A
P/B	6.08
P/tB	7.63
EV/EBITDA	72.43

EPS(TTM)-0.3

EYN/A

EPS(NY)1.34

Fwd EY17.21%

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS8.01

BVpS1.28

TBVpS1.02

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-8.34%
ROE	-23.59%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	95.25%
FCFM	N/A

ROA(3y)-6%

ROA(5y)-4.94%

ROE(3y)-24.19%

ROE(5y)-19.4%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.01%

GM growth 5YN/A

F-ScoreN/A

Asset Turnover2.21

Health

		Industry Rank	Sector Rank
Debt/Equity	0.39
Debt/FCF	N/A
Debt/EBITDA	4.36
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.69
Quick Ratio	1.08
Altman-Z	4.32

F-ScoreN/A

WACC7.24%

ROIC/WACCN/A

Cap/Depr(3y)93.52%

Cap/Depr(5y)80.3%

Cap/Sales(3y)1.3%

Cap/Sales(5y)2.22%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)64.98%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%192.84%

EPS Next Y2733.33%

EPS Next 2Y558.28%

EPS Next 3Y271.65%

EPS Next 5Y-46.37%

Revenue 1Y (TTM)-2.51%

Revenue growth 3Y3.08%

Revenue growth 5YN/A

Sales Q2Q%85.45%

Revenue Next Year17.2%

Revenue Next 2Y34.67%

Revenue Next 3Y25.87%

Revenue Next 5Y14.16%

EBIT growth 1Y76.75%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year343.64%

EBIT Next 3Y95.54%

EBIT Next 5Y51.49%

FCF growth 1Y-158.31%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-126.1%

OCF growth 3YN/A

OCF growth 5YN/A

2CRSI SA (AL2SI.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens